| Literature DB >> 33381480 |
Mira N Moufarrej1, Ronald J Wong2, Gary M Shaw2, David K Stevenson2, Stephen R Quake1.
Abstract
In recent years, there have been major advances in the application of non-invasive techniques to predict pregnancy-related complications, for example by measuring cell-free RNA (cfRNA) in maternal blood. In contrast to cell-free DNA (cfDNA), which is already in clinical use to diagnose fetal aneuploidy, circulating RNA levels can correspond with tissue-specific gene expression and provide a snapshot of prenatal health across gestation. Here, we review the physiologic origins of cfRNA and its novel applications and corresponding challenges to monitor fetal and maternal health and predict pregnancy-related complications.Entities:
Keywords: IUGR; cell-free RNA; prediction; preeclampsia; preterm birth; transcriptome
Year: 2020 PMID: 33381480 PMCID: PMC7767905 DOI: 10.3389/fped.2020.605219
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418